NEW YORK — Skin care company La Roche-Posay has developed the new Redermic [C], an anti-wrinkle firming moisturizer that was inspired by the growing popularity of injectable filler technology.
When treating skin-aging concerns, dermatologists implement a variety of procedures, treatments and ingredients. Influenced by minimally invasive hyaluronic acid filler injectables, La Roche-Posay incorporates fragmented hyaluronic acid. This smaller molecule size (versus other topical hyaluronic acid molecules) allows for better diffusion to help visibly plump the skin, the company stated.
Dermatologists also incorporate such collagen-building treatments as prescription-strength retinoids and antioxidant ingredients, like vitamins A, C and E. Redermic [C] contains 5% pure vitamin C, a powerful antioxidant known for its ability to help synthesize collagen and even minimize the appearance of wrinkles. Finally, the product includes mannose, a sugar molecule that smoothes the skin’s surface and evens tone by optimizing the interaction of skin and light.
“Aesthetic procedures have become one of the fastest-growing areas of dermatology, because more women want to look and feel younger with the added benefits of lower costs and shorter recovery time,” stated Dr. Dina Anderson. “Redermic [C] is an effective adjunct to use in conjunction with many minimally invasive procedures, like fillers, as a way to continue combating wrinkles over time.”
Redermic [C] has an ultra-rich, melt-in texture that leaves a nongreasy finish. Noncomedogenic, paraben-free, fragrance-free, dermatologist-tested and safe for sensitive and dry skin, it can be used in the morning and night on the face and neck.
Redermic [C] from La Roche-Posay has a suggested retail price of $53.95 for normal/combination, $53.95 for dry, $53.95 for UV and $43.95 for eyes. The line will be offered beginning in September at select physicians’ offices and select CVS/pharmacy, Ulta, Walgreens and Duane Reade locations.